Congress is out of session until Monday, November 9 for the midterm campaign. No new roll-call votes until then; the last were the House on Sep 16 and the Senate on Sep 30.

Money / PACs

Orchard Therapeutics North America

Orchard Therapeutics North America Political Action Committee

Corporate PAC FEC C00916072

FollowFEC filings
Influence at a glance · Jan 2025 – Sep 2026Jan 25 – Sep 26 How we count
PAC giving to candidates$1K
Company lobbying, all issues $2.1M

Giving: FEC filings, net of refunds. Lobbying: the company’s own LD-2 reports, all issues, rounded to the nearest $10,000 each quarter. Two different filers, same 21 months.Lobbying: all issues, rounded to the nearest $10,000. Two filers, same 21 months. This PAC gives money raised from the company’s employees; the company itself can’t give to campaigns from its treasury.

Lobbying spend by quarter since 2015Spend by quarter Pro

Free account See Pro

What they lobby on

Method

Orchard Therapeutics North America reported federal lobbying in 8 of the last 8 quarters (Q4 2024 to Q3 2026), with its own in-house lobbyists and 6 outside firms. What follows is what the filings say it lobbied on, not which way.

Issue areas ranked by quarters filedQ4 24 → Q3 26

  • Budget/Appropriations8 of 88/8
  • Health Issues8 of 88/8
  • Medical/Disease Research/Clinical Labs8 of 88/8
  • Medicare/Medicaid8 of 88/8
  • Pharmacy3 of 83/8

Bills named in the filings 9 bills, this period

4 more, 3 named in only one filing · Show all 9

From the filings

“Newborn screening and pharmaceuticals. The Accelerating Kids Access to Care Act (H.R. 1509/S. 752).”
Q3 2026 filing · Health Issues
“FDA Policies: Rare Disease Gene Therapy Approvals Newborn Screening, including Appropriations and Accelerating Implementation and Providing Resources for States to Implement for Metachromatic Leukodystrophy (MLD) H.R. 10571: Surge to Save Newborns Act”
Q3 2026 filing · Health Issues

Contacted as listed on the filings

  • U.S. House
  • U.S. Senate
  • Health & Human ServicesHHS
  • Executive Office of the PresidentEOP
  • Food & Drug AdministrationFDA
  • Centers For Medicare and Medicaid ServicesCMS

The House and Senate appear in every quarter; agencies in 6 of 8.

Every filing since 2015, with the lobbyists named and the quarters each bill appearsEvery filing since 2015 Pro

Free account See Pro

Source: Lobbying Disclosure Act filings (LD-2) by Orchard Therapeutics North America, Senate Office of Public Records. Filings are due 20 days after each quarter ends.

From FEC filings: direct gifts this PAC reported, net of refunds · How we count

Gave directly to 2 sitting members of Congress in 2025–26.

Everyone this PAC fundsPro

See every candidate and member Orchard Therapeutics North America gave to directly, how much, and how its money splits between the parties.

This part is in Pro. A free account lets you follow up to 3 people and get a weekly email about them; upgrade whenever you need more.

Create a free account See what Pro adds Log in